RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tianjin Lisheng Pharmaceutical Co Stock

Tianjin Lisheng Pharmaceutical Co EBIT 2024

Tianjin Lisheng Pharmaceutical Co EBIT

120.61 M CNY

Ticker

002393.SZ

ISIN

CNE100000NJ9

In 2024, Tianjin Lisheng Pharmaceutical Co's EBIT was 120.61 M CNY, a 96.31% increase from the 61.44 M CNY EBIT recorded in the previous year.

The Tianjin Lisheng Pharmaceutical Co EBIT history

YEAREBIT (undefined CNY)
2023120.61
202261.44
202131.74
202046.9
2019187.7
2018169.7
201793.8
2016110
2015129.6
201484.4
2013303.1
2012318.3
2011255.4
2010242.8
2009210.3
2008185.6
2007156

Tianjin Lisheng Pharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Tianjin Lisheng Pharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Tianjin Lisheng Pharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Tianjin Lisheng Pharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Tianjin Lisheng Pharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Tianjin Lisheng Pharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Tianjin Lisheng Pharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Tianjin Lisheng Pharmaceutical Co’s growth potential.

Tianjin Lisheng Pharmaceutical Co Revenue, EBIT and net profit per share

DateTianjin Lisheng Pharmaceutical Co RevenueTianjin Lisheng Pharmaceutical Co EBITTianjin Lisheng Pharmaceutical Co Net Income
20231.15 B CNY120.61 M CNY361.83 M CNY
20221.15 B CNY61.44 M CNY93.61 M CNY
20211.09 B CNY31.74 M CNY122.11 M CNY
20201.14 B CNY46.9 M CNY8.6 M CNY
20191.62 B CNY187.7 M CNY188.1 M CNY
20181.5 B CNY169.7 M CNY185 M CNY
20171.03 B CNY93.8 M CNY116.8 M CNY
2016846.9 M CNY110 M CNY115.6 M CNY
2015774.8 M CNY129.6 M CNY114.2 M CNY
2014773.7 M CNY84.4 M CNY92.9 M CNY
20131.04 B CNY303.1 M CNY293 M CNY
20121.12 B CNY318.3 M CNY297.1 M CNY
2011997.7 M CNY255.4 M CNY345.9 M CNY
2010738 M CNY242.8 M CNY203.4 M CNY
2009595.7 M CNY210.3 M CNY154.5 M CNY
2008592.5 M CNY185.6 M CNY132 M CNY
2007393.3 M CNY156 M CNY132.4 M CNY

Tianjin Lisheng Pharmaceutical Co stock margins

The Tianjin Lisheng Pharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Tianjin Lisheng Pharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Tianjin Lisheng Pharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Tianjin Lisheng Pharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the Tianjin Lisheng Pharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Tianjin Lisheng Pharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Tianjin Lisheng Pharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Tianjin Lisheng Pharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Tianjin Lisheng Pharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Tianjin Lisheng Pharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Tianjin Lisheng Pharmaceutical Co Margin History

Tianjin Lisheng Pharmaceutical Co Gross marginTianjin Lisheng Pharmaceutical Co Profit marginTianjin Lisheng Pharmaceutical Co EBIT marginTianjin Lisheng Pharmaceutical Co Profit margin
202358.21 %10.46 %31.38 %
202255.98 %5.36 %8.16 %
202157.12 %2.91 %11.18 %
202060.56 %4.11 %0.75 %
201971.79 %11.62 %11.64 %
201871.38 %11.29 %12.3 %
201763.04 %9.11 %11.35 %
201656.55 %12.99 %13.65 %
201555.52 %16.73 %14.74 %
201454.67 %10.91 %12.01 %
201364.52 %29.02 %28.05 %
201261.48 %28.49 %26.6 %
201157.48 %25.6 %34.67 %
201057.03 %32.9 %27.56 %
200960.8 %35.3 %25.94 %
200857 %31.32 %22.28 %
200768.12 %39.66 %33.66 %

Tianjin Lisheng Pharmaceutical Co Aktienanalyse

What does Tianjin Lisheng Pharmaceutical Co do?

Tianjin Lisheng Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Tianjin Lisheng Pharmaceutical Co's EBIT

Tianjin Lisheng Pharmaceutical Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Tianjin Lisheng Pharmaceutical Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Tianjin Lisheng Pharmaceutical Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Tianjin Lisheng Pharmaceutical Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Tianjin Lisheng Pharmaceutical Co stock

How much did Tianjin Lisheng Pharmaceutical Co achieve in EBIT for the current year?

In the current year, Tianjin Lisheng Pharmaceutical Co has achieved an EBIT of 120.61 M CNY.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Tianjin Lisheng Pharmaceutical Co.

How has the EBIT of Tianjin Lisheng Pharmaceutical Co developed in recent years?

The EBIT of Tianjin Lisheng Pharmaceutical Co has increased by 96.307% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Tianjin Lisheng Pharmaceutical Co?

The EBIT of Tianjin Lisheng Pharmaceutical Co is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Tianjin Lisheng Pharmaceutical Co pay?

Over the past 12 months, Tianjin Lisheng Pharmaceutical Co paid a dividend of 0.3 CNY . This corresponds to a dividend yield of about 1.95 %. For the coming 12 months, Tianjin Lisheng Pharmaceutical Co is expected to pay a dividend of 0.3 CNY.

What is the dividend yield of Tianjin Lisheng Pharmaceutical Co?

The current dividend yield of Tianjin Lisheng Pharmaceutical Co is 1.95 %.

When does Tianjin Lisheng Pharmaceutical Co pay dividends?

Tianjin Lisheng Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, July, July, June.

How secure is the dividend of Tianjin Lisheng Pharmaceutical Co?

Tianjin Lisheng Pharmaceutical Co paid dividends every year for the past 13 years.

What is the dividend of Tianjin Lisheng Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0.3 CNY are expected. This corresponds to a dividend yield of 1.95 %.

In which sector is Tianjin Lisheng Pharmaceutical Co located?

Tianjin Lisheng Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tianjin Lisheng Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tianjin Lisheng Pharmaceutical Co from 5/28/2024 amounting to 0.429 CNY, you needed to have the stock in your portfolio before the ex-date on 5/28/2024.

When did Tianjin Lisheng Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 5/28/2024.

What was the dividend of Tianjin Lisheng Pharmaceutical Co in the year 2023?

In the year 2023, Tianjin Lisheng Pharmaceutical Co distributed 0.3 CNY as dividends.

In which currency does Tianjin Lisheng Pharmaceutical Co pay out the dividend?

The dividends of Tianjin Lisheng Pharmaceutical Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Tianjin Lisheng Pharmaceutical Co

Our stock analysis for Tianjin Lisheng Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tianjin Lisheng Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.